Infant Formula Lipid Architecture for Breastfed-Like Growth
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Commercial infant formulas differ in growth trajectories from breastfed infants, leading to higher weight gain and BMI in formula-fed infants, which is not similar to the growth pattern of breastfed infants, especially after 4 months of age.
Innovation Solution
An infant formula with lipid globules of larger size (mode diameter of at least 1.0 µm and 45% by volume) coated with phospholipids, providing a nutritional composition of 3-7 g lipid/100 kcal, 1.25-5 g protein/100 kcal, and 6-18 g digestible carbohydrate/100 kcal, mimicking human milk's lipid structure to promote a growth trajectory closer to that of breastfed infants.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Quantity of substance
If commercial infant formula uses standard lipid globules with small size and protein coating, then the formula provides adequate nutrition, but the growth trajectory diverges from breastfed infants with higher weight gain and BMI after 4 months
Solution Approach 1:
The patent changes the physical parameters of lipid globules (increasing diameter to 2-12 µm with mode diameter ≥1.0 µm) and chemical parameters (phospholipid coating composition) to mimic human milk lipid structure, thereby aligning the growth trajectory with breastfed infants while maintaining adequate nutrition
Solution Approach 2:
The patent uses composite lipid globules consisting of a lipid core coated with phospholipids (including sphingomyelin, phosphatidylcholine, phosphatidylethanolamine, and phosphatidylserine) to recreate the complex structure of human milk fat globules, which resolves the contradiction between providing sufficient calories and achieving breastfed-like growth patterns
2Ease of operation
If infant formula lipid globules are made larger with phospholipid coating to mimic human milk, then the growth trajectory becomes similar to breastfed infants, but the manufacturing complexity increases
Solution Approach 1:
The patent specifies precise parameter ranges (lipid globule diameter 2-12 µm, mode diameter ≥1.0 µm, phospholipid composition ratios) that can be controlled through standard emulsification and spray-drying processes, making the complex structure manufacturable with existing technology
3Quantity of substance
If infant formula uses lower protein and caloric density to reduce weight gain, then the growth trajectory becomes slower, but the infant may experience inadequate growth in the first 4 months
Solution Approach 1:
The patent maintains protein content (1.25-5 g/100 kcal) and caloric density within standard ranges while changing the lipid globule characteristics, thereby achieving appropriate weight gain rate without compromising adequate growth in the first 4 months
Solution Approach 2:
The patent applies different properties to different components: standard protein and carbohydrate composition for adequate early growth, while modifying lipid globule size and phospholipid coating to control long-term weight gain rate and achieve breastfed-like growth trajectory
Data Source
Figure 1
Figure 2
Figure 3
AI summary
The present invention relates to formulae for infants comprising large lipid globules and/or lipid globules with a coating of phospholipids for rendering the growth trajectory or body development during the first year of life more similar to that observed for human milk fed infants.